ctrl K

Inozyme Pharma Inc. (INZY)

NASDAQ: INZY · Real-Time Price · USD

1.20

0.05 (4.35%)

At close: May 01, 2025, 3:59 PM

1.20

0.00%

Pre-market: May 02, 2025, 07:00 AM EDT

Inozyme Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.29M	1.18M	1.05M	217K	83K	26K
Gross Profit	n/a	-1.29M	-1.18M	-1.05M	-217K	-83K	-26K
Operating Income	-104.03M	-75.64M	-68.67M	-56.65M	-57.04M	-20.81M	-11.59M
Interest Income	7.67M	7.84M	1.93M	211K	370K	1.11M	284K
Pretax Income	-102.02M	-71.17M	-67.06M	-56.62M	-56.42M	-19.72M	-6.96M
Net Income	-102.02M	-71.17M	-65.45M	-56.41M	-55.84M	-18.62M	-6.96M
Selling & General & Admin	20.8M	20.8M	20.83M	18.93M	10.55M	4.59M	3.49M
Research & Development	83.23M	54.05M	47.85M	37.72M	46.49M	16.22M	8.1M
Other Expenses	n/a	n/a	-319K	-189K	247K	-24K	4.34M
Operating Expenses	104.03M	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Interest Expense	-5.56M	3.33M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Income Tax Expense	n/a	n/a	-1.61M	-211K	-587K	-1.11M	4.63M
Shares Outstanding (Basic)	62.81M	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
Shares Outstanding (Diluted)	62.81M	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
EPS (Basic)	-1.62	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EPS (Diluted)	-1.62	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EBITDA	-104.03M	-74.81M	-65.88M	-55.97M	-56.82M	-20.72M	-11.57M
EBIT	-107.58M	-75.64M	-68.67M	-56.62M	-57.04M	-20.81M	-11.59M
Depreciation & Amortization	3.55M	833K	1.18M	1.05M	217K	83K	26K